Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

15-Point Test Gauges Alzheimer's Risk

In older volunteeers, the screening tool predicted start of dementia

By Amanda Gardner
HealthDay Reporter


Related Encyclopedia
 border=
Acoustic Neurinoma
Alzheimer's Disease
Bell's Palsy
Brain and Spinal Cord Magnetic Resonance Imaging
More...

Related Healthscout Videos
 border=
Custom Ankle Replacements
Shutting Down Tremor.
Disaster Heart Attacks
Weighted Belt for Autism?
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Erectile Dysfunction
What is a Heart Attack?
More...

Related Drug Information
 border=
Actonel
Adderal XR
Concerta
Coumadin
More...

Related News Articles
 border=
All Ages at Risk for H1N1 Complications
Diabetes Slows Alzheimer's Memory Loss?
Vision Troubles may Signal Alzheimer's
Study: Preserving Heart Function Prevents Aging
More...

WEDNESDAY, May 13 (HealthDay News) -- Researchers have developed a 15-point test that can identify the risk for developing Alzheimer's disease in older people.

But the tool, which involves both simple questions as well as complex physiological testing, may not be practical for clinical use.

Text Continues Below



"Some of the points on there are fairly easy, such as age and mental status exams. We do those already in the clinic," said Dr. Michael Palm, an assistant professor of neuroscience and experimental therapeutics and internal medicine at the Texas A&M Health Science Center College of Medicine. "But, as far as the screening tests, I don't think we can order MRI and genetic testing on everybody who starts getting older."

And the simpler parts of the system, Palm added, are already routinely used in screening for Alzheimer's.

Palm was not involved with the study, conducted by researchers at the University of California, San Francisco, and published online May 13 issue in the journal Neurology.

According to the authors of the study, which was supported by the U.S. National Institutes of Health, while there are ways to predict dementia two decades in the future in middle-aged individuals, there is no system to predict onset of the disease later in life.

The study involved 3,375 people, mean age 76, none of whom had dementia when they were enrolled. About 60 percent were women, and 15 percent were black.

Risk factors in the index included: older age; poor performance on cognitive tests; low body-mass index; having the predisposing apolipoprotein E (APOE) gene; abnormal MRI findings; thicker carotid artery measurements and other vascular indications; slowness buttoning a shirt or performing other physical tasks; and not drinking alcohol.

Only 4 percent of participants with low scores went on to develop dementia (Alzheimer's and other forms of dementia including vascular dementia) over the next six years, versus 23 percent of those with mid-range scores and 56 percent of those with high scores.

Page:  1 | 2 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 5/13/2009

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.





SOURCES: Gary J. Kennedy, M.D., director, geriatric psychiatry, Montefiore Medical Center, New York City; Michael Palm, M.D., assistant professor, neuroscience and experimental therapeutics and internal medicine, Texas A&M Health Science Center College of Medicine, and director, Parkinson's and Headache programs, Texas Brain and Spine Institute, Bryan; May 13, 2009, Neurology, online


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy